SAN DIEGO — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the closing of its initial public offering of 69,000,000 shares of Class A common stock, including the full exercise of the underwriters’ option to purchase up to 9,000,000 additional shares of […]
Robert Wicke brings comprehensive leadership to innovative start-up SAN DIEGO — Omniome, Inc., developer of a novel DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announces the appointment of Robert Wicke as Chief Executive Officer. He will immediately assume day-to-day leadership and join Omniome’s Board of Directors. Robert brings over 30 years’ experience […]
An experienced leader in corporate development and operations steps into new role at growing start-up SAN DIEGO – Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, announces the promotion of Kelly Perez to Chief Operating Officer. Kelly, who has been Senior Vice President, Finance & Operations of Omniome […]
SAN DIEGO, Calif. — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the pricing of its upsized initial public offering of 60,000,000 shares of Class A common stock at a public offering price of $27.00 per share, before underwriting discounts and […]
Fast and accurate method for simultaneous detection of four species of pathogenic Aspergillus: A. flavus, A. fumigatus, A. niger, A. terreus, in cannabis and cannabis-infused products POTSDAM, Germany — BIOTECON Diagnostics is pleased to announce the launch of its highly convenient, sensitive, rapid and easy to use lyophilized test kit – the foodproof Aspergillus Detection LyoKit. Within two days […]
SEATTLE — TwinStrand Biosciences today announced it has entered into a worldwide non-exclusive agreement to sublicense two foundational patent families to Foundation Medicine and its affiliates relating to TwinStrand Duplex Sequencing™ error-correction technology. Duplex Sequencing increases the accuracy of next-generation sequencing as much as 10,000 times, allowing the detection of ultra-low frequency mutations that would […]
NEW YORK, NY — Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading biosciences and diagnostics company, announced today that Mary Tagliaferri, MD, has been appointed to the company’s Board of Directors effective immediately. “In 2020, Enzo reported significant progress in advancing our business plan to achieve profitability including strong results in many areas […]
Consortium aims to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S. to inform medical management and improve patient outcomes. WASHINGTON — Seven leading diagnostics companies and laboratory service providers have formed the Access to Comprehensive Genomic Profiling Coalition (ACGP). The goal of the organization is to collectively advocate for appropriate broad […]
Photo by National Cancer Institute on Unsplash shows human colorectal cancer cells treated with an inhibitor under study as a cancer therapy. Created by Yves Pommier, Rozenn Josse. Griffith University will establish a Centre of Excellence (CoE) in spatial biology in collaboration with Nanostring Technologies, a publicly held provider of life science tools for translational research […]
ST. LOUIS & SAN DIEGO — PierianDx, the leading clinical genomics informatics company, and Bench International, a leading global executive search firm, jointly announce the appointment of Mark McDonough as Chief Executive Officer (CEO) and member of the Board of Directors of PierianDx, effective immediately. In his new role, McDonough will help fulfill the company’s […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
